93 related articles for article (PubMed ID: 28592188)
1. Polymer-coated cardiopulmonary bypass circuit attenuates upregulation of both proteases/protease inhibitors and platelet degranulation in pigs.
Suehiro S; Shimizu K; Imai K; Niii A; Akeho K; Nakata H; Yamaguchi A; Matsumoto KI; Oda T
Perfusion; 2017 Nov; 32(8):645-655. PubMed ID: 28592188
[TBL] [Abstract][Full Text] [Related]
2. Hypothermic effects on gas exchange performance of membrane oxygenator and blood coagulation during cardiopulmonary bypass in pigs.
Akeho K; Nakata H; Suehiro S; Shimizu K; Imai K; Yamaguchi A; Matsumoto KI; Oda T
Perfusion; 2020 Oct; 35(7):687-696. PubMed ID: 32009532
[TBL] [Abstract][Full Text] [Related]
3. Experimental research with synthetic copolymer-coated cardiopulmonary bypass circuits: inflammatory and thrombogenicity analysis.
Gabriel EA; Montevilla FM; Chida VV; Dias FN; Montoya CV; Otsubo H; Pires ZF; Nogaroto SL
Artif Organs; 2012 Jan; 36(1):110-4. PubMed ID: 21848861
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility of cardiopulmonary bypass circuit with new polymer Senko E-Ternal Coating™.
Fukui T; Nishida H; Takanashi S
Perfusion; 2015 Oct; 30(7):572-9. PubMed ID: 25837980
[TBL] [Abstract][Full Text] [Related]
5. Platelet preservation during cardiopulmonary bypass with iloprost and Duraflo-II heparin-coated surfaces.
Palatianos GM; Dewanjee MK; Smith W; Novak S; Hsu LC; Kapadvanjwala M; Sfakianakis GN; Kaiser GA
ASAIO Trans; 1991; 37(4):620-2. PubMed ID: 1722689
[TBL] [Abstract][Full Text] [Related]
6. Poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit can reduce transfusion of platelet products compared to heparin-coated circuit during aortic arch surgery.
Hosoyama K; Ito K; Kawamoto S; Kumagai K; Akiyama M; Adachi O; Kawatsu S; Sasaki K; Suzuki M; Sugawara Y; Shimizu Y; Saiki Y
J Artif Organs; 2016 Sep; 19(3):233-40. PubMed ID: 26909493
[TBL] [Abstract][Full Text] [Related]
7. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass.
Ask A; Holt D; Smith L
J Extra Corpor Technol; 2006 Mar; 38(1):27-32. PubMed ID: 16637520
[TBL] [Abstract][Full Text] [Related]
8. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
9. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children.
Eisses MJ; Geiduschek JM; Jonmarker C; Cohen GA; Chandler WL
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):28-34. PubMed ID: 17289476
[TBL] [Abstract][Full Text] [Related]
10. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy.
Ikuta T; Fujii H; Shibata T; Hattori K; Hirai H; Kumano H; Suehiro S
Ann Thorac Surg; 2004 May; 77(5):1678-83. PubMed ID: 15111165
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass.
De SF; Van BY; Caes F; François K; Arnout J; Bossuyt X; Taeymans Y; Van NG
Perfusion; 2002 Jan; 17(1):39-44. PubMed ID: 11817528
[TBL] [Abstract][Full Text] [Related]
12. Influence of cardiopulmonary bypass on the interaction of recombinant factor VIIa with activated platelets.
Kjalke M; Runge M; Rojkjaer R; Steinbruchel D; Johansson PI
J Extra Corpor Technol; 2009 Jun; 41(2):97-104. PubMed ID: 19681308
[TBL] [Abstract][Full Text] [Related]
13. A comparative evaluation of the effect of pump type and heparin-coated surfaces on platelets during cardiopulmonary bypass.
Misoph M; Babin-Ebell J; Schwender S
Thorac Cardiovasc Surg; 1997 Dec; 45(6):302-6. PubMed ID: 9477463
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study on heparin-free cardiopulmonary bypass using nafamostat mesilate (FUT-175) and heparin-coated circuit].
Takano H; Miyamoto Y; Kaneko M; Matsuwaka R; Kuratani T; Amemiya A; Nakano S; Matsuda H
Nihon Kyobu Geka Gakkai Zasshi; 1993 Nov; 41(11):2166-73. PubMed ID: 8283086
[TBL] [Abstract][Full Text] [Related]
15. The effect of nitric oxide on platelets when delivered to the cardiopulmonary bypass circuit.
Lowson SM; Hassan HM; Rich GF
Anesth Analg; 1999 Dec; 89(6):1360-5. PubMed ID: 10589608
[TBL] [Abstract][Full Text] [Related]
16. Changes in platelet aggregation during cardiopulmonary bypass: comparison of poly-2-methoxyethylacrylate and heparin as a circuit coating material.
Izuha H; Hattori M; Igari T; Wakamatsu D; Watanabe M; Yokoyama H
J Artif Organs; 2005; 8(1):41-6. PubMed ID: 15951979
[TBL] [Abstract][Full Text] [Related]
17. Designing an experimental method for assessing biocompatibility of circuit coatings using biomarkers for platelet activation during cardiopulmonary bypass.
Sancheti M; Rentschler M; Bolch C; Li W; Necco K; Rath T; Esfandiarei M; Darban N
J Extra Corpor Technol; 2024 Jun; 56(2):37-44. PubMed ID: 38888546
[TBL] [Abstract][Full Text] [Related]
18. A new method for quantitation of platelet microthrombi and microemboli from cardiopulmonary bypass in organs using 111In labeled platelets.
Dewanjee MK; Zhai P; Hsu LC; Twardock AR
ASAIO J; 1997; 43(5):M701-5. PubMed ID: 9360137
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of poly(2-methoxyethylacrylate) in primary coronary artery bypass grafting.
Vang SN; Brady CP; Christensen KA; Isler JR; Allen KR
J Extra Corpor Technol; 2005 Mar; 37(1):23-31. PubMed ID: 15804153
[TBL] [Abstract][Full Text] [Related]
20. Emboli from an extraluminal blood flow hollow fiber oxygenator with and without an arterial filter during cardiopulmonary bypass in a pig model.
Dewanjee MK; Wu SM; Kapadvanjwala M; De D; Dewanjee S; Gonzalez L; Novak S; Hsu LC; Perryman RA; Duncan RC; Serafini AN; Sfakianakis GN; Horton AF
ASAIO J; 1996; 42(6):1010-8. PubMed ID: 8959277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
